Outcomes in pediatric relapsed/refractory anaplastic large cell lymphoma: A multi-institutional retrospective analysis

被引:0
|
作者
Marks, Lianna Jean
Ritter, Victor
Schultz, Liora M.
Lowe, Eric J.
Aftandilian, Catherine
机构
[1] Stanford Univ, Sch Med, Palo Alto, CA USA
[2] Childrens Hosp Kings Daughters Surg Grp, Norfolk, VA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
10032
引用
收藏
页数:1
相关论文
共 50 条
  • [1] A Multi-Institutional Outcomes Analysis of Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated with Ibrutinib
    Winter, Allison Marie
    Landsburg, Daniel J.
    Hernandez-Ilizaliturri, Francisco J.
    Reddy, Nishitha
    Smith, Stephen
    Shadman, Mazyar
    Caimi, Paolo
    Jagadeesh, Deepa
    Smith, Mitchell R.
    Hill, Brian T.
    BLOOD, 2016, 128 (22)
  • [2] MULTI-INSTITUTIONAL ANALYSIS OF PEDIATRIC RELAPSED/REFRACTORY CENTRAL NERVOUS SYSTEM GERM CELL TUMORS
    Nagabushan, Sumanth
    Dhall, Girish
    Abdelbaki, Mohamed
    NEURO-ONCOLOGY, 2022, 24 : 58 - 59
  • [3] Strategy for Pediatric Patients with Relapsed or Refractory Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma: A Review
    Noguchi, Kazuhiro
    Ikawa, Yasuhiro
    CANCERS, 2023, 15 (24)
  • [4] A multi-institutional outcomes analysis of patients with relapsed or refractory DLBCL treated with ibrutinib
    Winter, Allison M.
    Landsburg, Daniel J.
    Mato, Anthony R.
    Isaac, Krista
    Hernandez-Ilizaliturri, Francisco J.
    Reddy, Nishitha
    Smith, Stephen
    Shadman, Mazyar
    Smith, Mitchell R.
    Caimi, Paolo
    Jagadeesh, Deepa
    Hill, Brian T.
    BLOOD, 2017, 130 (14) : 1676 - 1679
  • [5] MULTI-INSTITUTIONAL ANALYSIS OF PEDIATRIC RELAPSED/REFRACTORY CENTRAL NERVOUS SYSTEM GERMINOMA.
    McGlynn, Mary Claire
    Abu-Arja, Mohammad H.
    Nagabushan, Sumanth
    Zaghloul, Mohamed Saad
    Elhemaly, Ahmed
    Bertrand, Kelsey
    Gajjar, Amar
    Alias, Hamidah
    Cappellano, Andrea
    Graham, Richard
    Baglivo, Sofia Jares
    Bhadri, Vivek
    Govender, Dinisha
    Abdelbaki, Mohamed S.
    NEURO-ONCOLOGY, 2023, 25
  • [6] A retrospective analysis of ibrutinib outcomes in relapsed or refractory mantle cell lymphoma
    Lee, Yong-Pyo
    Jung, Ye Ji
    Cho, Junhun
    Ko, Young Hyeh
    Kim, Won Seog
    Kim, Seok Jin
    Yoon, Sang Eun
    BLOOD RESEARCH, 2023, 58 (04) : 208 - 220
  • [7] Pediatric relapsed/refractory ALK-positive anaplastic large cell lymphoma treatment and outcomes in the targeted-drug era
    Marks, Lianna J.
    Ritter, Victor
    Agrusa, Jennifer E.
    Kamdar, Kala Y.
    Rivers, Julie
    Gardner, Rebecca
    Ehrhardt, Matthew J.
    Devine, Kaitlin J.
    Phillips, Charles A.
    Reilly, Anne
    August, Keith
    Weinstein, Joanna
    Satwani, Prakash
    Forlenza, Christopher J.
    Smith, Christine Moore
    Greer, Chelsee
    Afify, Zeinab
    Lin, Carol H.
    Belsky, Jennifer A.
    Ding, Hilda
    Hoogstra, David
    Toner, Keri
    Link, Michael P.
    Schultz, Liora M.
    Lowe, Eric J.
    Aftandilian, Catherine
    BLOOD ADVANCES, 2025, 9 (06) : 1356 - 1365
  • [8] Relapsed or refractory anaplastic large cell lymphoma: Brentuximab vedotin of course!
    Paillassa, Jerome
    HEMATOLOGIE, 2018, 24 (01): : 19 - 21
  • [9] A multi-institutional analysis of peritransplantation radiotherapy in patients with relapsed/refractory Hodgkin lymphoma undergoing autologous stem cell transplantation
    Milgrom, Sarah A.
    Jauhari, Shekeab
    Plastaras, John P.
    Nieto, Yago
    Dabaja, Bouthaina S.
    Pinnix, Chelsea C.
    Smith, Grace L.
    Allen, Pamela K.
    Lukens, J. Nicholas
    Maity, Amit
    Oki, Yasuhiro
    Fanale, Michelle A.
    Nasta, Sunita D.
    CANCER, 2017, 123 (08) : 1363 - 1371
  • [10] Retrospective analysis of clinical features and treatment outcomes of children with anaplastic large cell lymphoma: a single institutional experience
    Mahreen, A.
    Wali, R. M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 : 52 - 52